InvestorsHub Logo
Followers 288
Posts 57752
Boards Moderated 7
Alias Born 08/29/2007

Re: None

Monday, 10/07/2024 2:43:16 PM

Monday, October 07, 2024 2:43:16 PM

Post# of 76
Good morning! In the latest GLP-1 news, the FDA reported last week that Eli Lilly’s weight loss and diabetes drug Mounjaro is no longer facing a shortage. This means pharmacy companies that have been compounding the medication, a process that uses the same ingredients and is only allowed in times of shortages, can no longer do so. Novo Nordisk’s Ozempic and Wegovy are not affected by this, and will likely continue to be distributed by compounding pharmacies, including Hims and Hers.

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HIMS News